Berenberg lowered the firm’s price target on Grifols (GRFS) to EUR 15.50 from EUR 15.60 and keeps a Buy rating on the shares.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Grifols receives FDA approval to treat surgical bleeding with FS solution
- Grifols partners with BARDA for PoC testing of ocular immunoglobulin
- Grifols subsidiary GigaGen awarded U.S. BARDA contract
- CNMV initiates disciplinary proceedings against Grifols, Gotham, GIP
- Grifols says sanction not material, won’t impact financial statements